Surprise findings argue for caution about testosterone use in men at risk for fracture
Findings support emphasis on markers of frailty related to, but not dependent on, age
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Large database study reveals lingering health consequences of decades-old discrimination
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Additional analyses of the two trials presented at 2023 ESC Congress
But findings apply only to middle-aged or older men with confirmed hypogonadism
Findings hold implications for screening and potential nonsurgical therapy
Potential benefits include clinical guidance, TAVR outcome prediction, device testing
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Sophisticated in vivo modeling can enhance device development and therapy testing